Migraine Treatment Guidelines

Introduction to Migraine Treatment

The American Academy of Family Physicians recommends prochlorperazine (Compazine) 25 mg orally, with a maximum of three doses per 24 hours, combined with diphenhydramine (Benadryl) to prevent extrapyramidal side effects 1, 2

Prochlorperazine (Compazine) should be administered at 25 mg orally, with a maximum of three doses per 24 hours, as recommended by the American Academy of Family Physicians 1, 2

The American Academy of Family Physicians states that prochlorperazine has a high efficacy rating of 4 out of 4 for migraine treatment according to clinical guidelines 1, 2

The American Academy of Family Physicians advises that prochlorperazine is contraindicated in patients with CNS depression or those using adrenergic blockers, with common adverse effects including hypotension, tachycardia, arrhythmias, akathisia, pseudo-parkinsonism, tardive dyskinesia, and dystonia 1, 2

The American Academy of Family Physicians recommends a treatment algorithm where first-line treatment for mild to moderate migraines starts with NSAIDs such as aspirin (650-1000 mg), ibuprofen (400-800 mg), or naproxen sodium (275-550 mg) 1, 3
The American Academy of Family Physicians and the Annals of Internal Medicine suggest that second-line treatment for moderate to severe migraines or if NSAIDs are ineffective, use the prochlorperazine/diphenhydramine cocktail 1, 2, 4
The American Academy of Family Physicians and the Annals of Internal Medicine recommend that third-line treatment for migraines unresponsive to the above treatments, consider triptans or DHE if not contraindicated 4, 5

The American Academy of Family Physicians and Praxis Medical Insights advise administering the medication as early as possible in the headache phase for maximum effectiveness 3
The American Academy of Family Physicians suggests that if significant nausea or vomiting is present, consider non-oral routes of administration such as prochlorperazine suppositories 3, 5

Praxis Medical Insights recommends assessing treatment response after each attack, documenting frequency, severity, and duration 3
The Annals of Internal Medicine and Praxis Medical Insights suggest considering preventive therapy if attacks occur frequently (two or more attacks per month) or are severe 4, 7
The American Academy of Family Physicians advises monitoring for extrapyramidal symptoms, even with diphenhydramine co-administration 1, 2
The Annals of Internal Medicine recommends that if treatment fails, reevaluate diagnosis and consider alternative therapies or specialist referral 4